<DOC>
	<DOCNO>NCT03085030</DOCNO>
	<brief_summary>The aim study evaluate effect antioxidant IVF outcome infertile patient undergo IVF expect produce low number egg compare control group . The investigator assume conception rate high patient take antioxidant supplementation . The patient give antioxidant drug one month start IVF trial daily mouth . Uniform protocol stimulation do cycle type short protocol know antagonist protocol . Egg retrieval do anesthesia . pregnancy test do 2 week embryo transfer . The investigator also assess number quality egg day egg pick . In addition , researcher assess number first second grade embryo put day embryo transfer .</brief_summary>
	<brief_title>Can Antioxidants Affect Pregnancy Rate Patients With Expected Low Number Egg Retrieval IVF Cycles ?</brief_title>
	<detailed_description>The primary aim study ass value antioxidant intake pregnancy rate IVF/ICSI ( invitro-fertilization/intracytoplasmic sperm injection ) cycle poor responder . participant fulfill eligibility criterion , inform consent take . Block randomization do patient allocate one two group . The first group take antioxidant tablet daily orally one month IVF/ICSI cycle . group take placebo follow regimen study group . Antagonist protocol do participant . Ovum pick do general anesthesia one oocytes reach 17 mm . The researcher embryo transfer day 2 3 ovum pickup . pregnancy test blood 2 week embryo transfer .</detailed_description>
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Infertility , Female</mesh_term>
	<mesh_term>Antioxidants</mesh_term>
	<criteria>Infertile female undergo IVF/ICSI cycle Poor responder identify 1 . A previous poor ovarian response ( le 3 oocyte conventional ovarian stimulation protocol ) 2 . An abnormal ovarian reserve test consider altered case antral follicle count le 5 follicle AMH ( antimullerian hormone ) less 1.5 ng/ml . 3 . FSH ( follicle stimulate hormone ) value 10 IU/mL . 1 . Any endocrine metabolic disorder diabetes thyroid dysfunction 2 . Any significant uterine anomaly , uterine cavity distortion , fibroid , hydrosalpinx advance endometriosis stage III IV 3 . Severe oligoasthenoteratozoospermia azoospermia exclude , well .</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>infertility</keyword>
	<keyword>IVF</keyword>
	<keyword>ICSI</keyword>
	<keyword>poor responder IVF/ICSI cycle</keyword>
	<keyword>antioxidant</keyword>
</DOC>